Dendritic Cells Matured with a TLR7/8 Agonist Induce T Helper 1 Cell Polarization, Activate NK Cells and Are Thus Highly Suitable for Application in Cancer Immunotherapy

被引：0
|
作者：
Lichtenegger, Felix S. [1 ]
Mueller, Katharina [1 ]
Hiddemann, Wolfgang [1 ]
Schendel, Dolores J. [2 ]
Subklewe, Marion [1 ]
机构：
[1] Klinikum Univ Munchen, Med Klin & Poliklin 3, Munich, Germany
[2] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：168 / 168
页数：1
相关论文
共 39 条
  • [11] The TLR7/8 Ligand R848 Is Superior In Generation of Monocyte Derived Dendritic Cells From AML Patients for the Induction of Potent T and NK Cell Immune Responses
    Dorfel, Daniela
    Beck, Barbara
    Geiger, Christiane
    Lichtenegger, Felix
    Lindner, Lysann
    Merk, Martina
    Schendel, Dolores
    Subklewe, Marion
    BLOOD, 2010, 116 (21) : 905 - 906
  • [12] The TLR7 agonist induces tumor regression both by promoting CD4+T cells proliferation and by reversing T regulatory cell-mediated suppression via dendritic cells
    Wang, Chenchen
    Zhou, Quan
    Wang, Xiaofeng
    Wu, Xiongyan
    Chen, Xuehua
    Li, Jianfang
    Zhu, Zhenggang
    Liu, Bingya
    Su, Liping
    ONCOTARGET, 2015, 6 (03) : 1779 - 1789
  • [13] Regulation of intestinal dendritic cell migration and activation by plasmacytoid dendritic cells, TNF-α and type 1 IFNs after feeding a TLR7/8 ligand
    Yrlid, Ulf
    Milling, Simon W. F.
    Miller, Joanna L.
    Cartland, Sian
    Jenkins, Christopher D.
    MacPherson, G. Gordon
    JOURNAL OF IMMUNOLOGY, 2006, 176 (09): : 5205 - 5212
  • [14] INCREASED TUMOR-SPECIFIC CD8+ T CELL INDUCTION BY DENDRITIC CELLS MATURED WITH A CLINICAL GRADE TLR-AGONIST IN COMBINATION WITH IFN-γ
    Vanderlocht, J.
    van Elssen, C. H. M. J.
    Senden-Gijsbers, B. L. M. G.
    Meek, B.
    Cloosen, S.
    Libon, C.
    Bos, G. M. J.
    Germeraad, W. T. V.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (01) : 35 - 50
  • [15] Human Dendritic Cells Stimulated via TLR7 and/or TLR8 Induce the Sequential Production of Il-10, IFN-γ, and IL-17A by Naive CD4+ T Cells
    Lombardi, Vincent
    Van Overtvelt, Laurence
    Horiot, Stephane
    Moingeon, Philippe
    JOURNAL OF IMMUNOLOGY, 2009, 182 (06): : 3372 - 3379
  • [16] Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade
    Tachinami, Hidetake
    Nishii, Naoto
    Xia, Yulong
    Kashima, Yoshihisa
    Ohno, Tatsukuni
    Nagai, Shigenori
    Li, Lixin
    Lau, Walter
    Tomihara, Kei
    Noguchi, Makoto
    Azuma, Miyuki
    ORAL ONCOLOGY, 2019, 91 : 21 - 28
  • [17] Differences of tumor-recruiting myeloid cells in murine squamous cell carcinoma influence the efficacy of immunotherapy combined with a TLR7 agonist and PD-L1 blockade
    Azuma, M.
    Tachinami, H.
    Nishii, N.
    Xia, Y.
    Kashima, Y.
    Nagai, S.
    Li, L.
    Tomihara, K.
    Noguchi, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1757 - 1757
  • [18] Dendritic Cells Pulsed with HAM/TSP Exosomes Sensitize CD4 T Cells to Enhance HTLV-1 Infection, Induce Helper T-Cell Polarization, and Decrease Cytotoxic T-Cell Response
    Joseph, Julie
    Premeaux, Thomas A.
    Tandon, Ritesh
    Murphy, Edward L.
    Bruhn, Roberta
    Nicot, Christophe
    Herrera, Bobby Brooke
    Lemenze, Alexander
    Alatrash, Reem
    Baffour Tonto, Prince
    Ndhlovu, Lishomwa C.
    Jain, Pooja
    VIRUSES-BASEL, 2024, 16 (09):
  • [19] Co-delivery of STING and TLR7/8 agonists in antigen-based nanocapsules to dendritic cells enhances CD8+T cell-mediated melanoma remission
    Schunke, Jenny
    Hueppe, Natkritta
    Mangazeev, Nicole
    Speth, Kai R.
    Rohde, Katja
    Scho, Felicia
    Bolduan, Vanessa
    Schneider, Paul
    Klaus, Tanja
    Kuske, Michael
    Grabbe, Stephan
    Landfester, Katharina
    Mailander, Volker
    Fichter, Michael
    NANO TODAY, 2024, 57
  • [20] Co-delivery of STING and TLR7/8 agonists in antigen-based nanocapsules to dendritic cells enhances CD8+T cell-mediated melanoma remission
    Schunke, J.
    Hueppe, N.
    Grabbe, S.
    Landfester, K.
    Mailaender, V.
    Fichter, M.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2023, 53 : 184 - 184
1234